After a sluggish 2024, hopes are high for a rebound in M&A activity as falling interest rates encourage investors to deploy capital into innovative, resilient healthcare businesses. Goodwin Procter’s Anne Stroude, Arvin Abraham, Mike Grainger and Sophie McGrath assess the outlook and highlight key trends While the healthcare financing market showed early signs of recovery…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
